Condition: Ischemic Cerebral Infarction · Sponsor: Beijing Tiantan Hospital
The Oris trial aims to evaluate whether the use of Ongericimab injection in patients with atherosclerotic ischemic cerebrovascular disease within 3 months of onset can reduce the risk of recurrent major cardiovascular events by achieving lower lipid-lowering target values (LDL-C \< 1.4 mmol/L).
This description comes directly from the study's public registry record.
Yongjun Wang, MD · +86 13911172565 · yongjunwang111@aliyun.com
Liye Dai, MD · +86 15010545290 · yezidailiye@163.com
Always discuss trial participation with your own doctor first.
| Fuyang People's Hospital | Fuyang, Anhui, China | — |
| The First Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | — |
| The First Hospital of Fangshan District, Beijing | Beijing, Beijing Municipality, China | — |
| Chongqing Sanbo Changan Hospital | Chongqing, Chongqing Municipality, China | — |
| The Fifth People's Hospital of Chongqing | Chongqing, Chongqing Municipality, China | — |
| The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College | Chongqing, Chongqing Municipality, China | — |
| Ningde People's Hospital | Ningde, Fujian, China | — |
| Minxian County Hospital of Traditional Chinese Medicine | Dingxi, Gansu, China | — |
| Shanghai General Hospital Jiuquan Hospital | Jiuquan, Gansu, China | — |
| Gansu Provincial Maternity and Child-care Hospital(Gansu Provincial Central Hospital) | Lanzhou, Gansu, China | — |
| The First People's Hospital of Yuzhong County | Lanzhou, Gansu, China | — |
| First People's Hospital of Tianshui | Tianshui, Gansu, China | — |
+ 187 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.